↓ Skip to main content

A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients

Overview of attention for article published in Orphanet Journal of Rare Diseases, May 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
33 Mendeley